These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33562622)

  • 1. Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide.
    Arshad J; Tong KKH; Movassaghi S; Söhnel T; Jamieson SMF; Hanif M; Hartinger CG
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Ru(η
    Arshad J; Hanif M; Movassaghi S; Kubanik M; Waseem A; Söhnel T; Jamieson SMF; Hartinger CG
    J Inorg Biochem; 2017 Dec; 177():395-401. PubMed ID: 28916262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
    Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
    Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand.
    Hanif M; Moon S; Sullivan MP; Movassaghi S; Kubanik M; Goldstone DC; Söhnel T; Jamieson SM; Hartinger CG
    J Inorg Biochem; 2016 Dec; 165():100-107. PubMed ID: 27470012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Ru and Os complexes of N-(4-chlorophenyl)pyridine-2-carbothioamide: Substitution of the labile chlorido ligand with phosphines.
    Riaz Z; Lee BYT; Stjärnhage J; Movassaghi S; Söhnel T; Jamieson SMF; Shaheen MA; Hanif M; Hartinger CG
    J Inorg Biochem; 2023 Apr; 241():112115. PubMed ID: 36731369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BODIPY-based Ru(II) and Ir(III) organometallic complexes of avobenzone, a sunscreen material: Potent anticancer agents.
    Gupta G; Cherukommu S; Srinivas G; Lee SW; Mun SH; Jung J; Nagesh N; Lee CY
    J Inorg Biochem; 2018 Dec; 189():17-29. PubMed ID: 30153544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of new polynuclear organometallic Ru(II), Rh(III) and Ir(III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents.
    Chellan P; Land KM; Shokar A; Au A; An SH; Taylor D; Smith PJ; Riedel T; Dyson PJ; Chibale K; Smith GS
    Dalton Trans; 2014 Jan; 43(2):513-26. PubMed ID: 24121555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning the cytotoxic properties of new ruthenium(III) and ruthenium(II) complexes with a modified bis(arylimino)pyridine Schiff base ligand using bidentate pyridine-based ligands.
    Garza-Ortiz A; Maheswari PU; Lutz M; Siegler MA; Reedijk J
    J Biol Inorg Chem; 2014 Jun; 19(4-5):675-89. PubMed ID: 24430199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
    Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
    Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity.
    Tong KKH; Hanif M; Lovett JH; Hummitzsch K; Harris HH; Söhnel T; Jamieson SMF; Hartinger CG
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32796732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the interactions of diruthenium anticancer agents with amino acids.
    Nazarov AA; Mendoza-Ferri MG; Hanif M; Keppler BK; Dyson PJ; Hartinger CG
    J Biol Inorg Chem; 2018 Oct; 23(7):1159-1164. PubMed ID: 30046902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility.
    Tremlett WDJ; Tong KKH; Steel TR; Movassaghi S; Hanif M; Jamieson SMF; Söhnel T; Hartinger CG
    J Inorg Biochem; 2019 Oct; 199():110768. PubMed ID: 31357065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of ferrocene appended Ru(II), Rh(III) and Ir(III) dipyrrinato complexes with DNA/protein, molecular docking and antitumor activity.
    Paitandi RP; Gupta RK; Singh RS; Sharma G; Koch B; Pandey DS
    Eur J Med Chem; 2014 Sep; 84():17-29. PubMed ID: 25014746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative solution equilibrium studies of antitumor ruthenium(η
    Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
    Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
    Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
    Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
    Liu Z; Salassa L; Habtemariam A; Pizarro AM; Clarkson GJ; Sadler PJ
    Inorg Chem; 2011 Jun; 50(12):5777-83. PubMed ID: 21618978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.